0001127602-19-006917.txt : 20190219 0001127602-19-006917.hdr.sgml : 20190219 20190219171755 ACCESSION NUMBER: 0001127602-19-006917 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190214 FILED AS OF DATE: 20190219 DATE AS OF CHANGE: 20190219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Christensen Bret CENTRAL INDEX KEY: 0001707443 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33462 FILM NUMBER: 19616067 MAIL ADDRESS: STREET 1: 600 TECHNOLOGY PARK DRIVE STREET 2: SUITE 200 CITY: BILLERICA STATE: MA ZIP: 01821 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INSULET CORP CENTRAL INDEX KEY: 0001145197 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043523891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: 978-600-7000 MAIL ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2019-02-14 0001145197 INSULET CORP PODD 0001707443 Christensen Bret C/O INSULET CORPORATION 100 NAGOG PARK ACTON MA 01720 1 SVP and CCO Common Stock 2019-02-14 4 F 0 510 84.83 D 10831 D This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations. Includes 4,671 restricted stock units granted on May 26, 2017, which vest one-half of the total units on May 26, 2019 and one-half of the total units on May 26, 2020; and 3,132 restricted stock units granted on February 14, 2018, which vest one-half of the total units on February 14, 2020 and one-half of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date. Includes the following shares purchased under the Insulet Corporation 2007 Employee Stock Purchase Plan: 241 shares purchased on May 31, 2018 and 84 shares purchased on November 30, 2018. /s/ David Colleran, attorney-in-fact 2019-02-19